T2 Biosystems to Report Second Quarter 2023 Financial Results on August 7, 2023

Rhea-AI Summary

T2 Biosystems, Inc. will report financial results for Q2 2023 on August 7, 2023. The conference call will be held at 4:30 p.m. Eastern Time. Investors can access the live webcast at www.t2biosystems.com and dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International) to listen to the conference call.

LEXINGTON, Mass., July 24, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that it will report financial results for the second quarter 2023 after market close Monday, August 7, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.t2biosystems.com, on the Investors page in the Events & Presentations section. To listen to the conference call, please dial 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International), passcode 420267, approximately ten to five minutes prior to the start time.

About T2 Biosystems:
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx^® Instrument, the T2Bacteria^® Panel, the T2Candida^® Panel, the T2Resistance^® Panel, and the T2SARS-CoV-2™ Panel and are powered by the proprietary T2 Magnetic Resonance (T2MR^®) technology. T2 Biosystems has an active pipeline of future products, including the T2Biothreat™ Panel, the Candida auris test, and T2Lyme™ Panel, as well as next-generation products for the detection of bacterial and fungal pathogens and associated antimicrobial resistance markers. For more information, please visit www.t2biosystems.com.

Investor Contact:
Philip Trip Taylor, Gilmartin Group
ir@T2Biosystems.com
415-937-5406

FAQ

When will T2 Biosystems report its financial results for Q2 2023?

T2 Biosystems will report its financial results for Q2 2023 on August 7, 2023.

What time will the conference call be held?

The conference call will be held at 4:30 p.m. Eastern Time.

How can investors access the live webcast of the event?

Investors can access the live webcast at www.t2biosystems.com.

What is the dial-in number for the conference call?

The dial-in number for the conference call is 1-888-506-0062 (US/Canada) or 1-973-528-0011 (International).

What is the passcode for the conference call?

The passcode for the conference call is 420267.

When should investors dial in to listen to the conference call?

Investors should dial in approximately ten to five minutes prior to the start time of the conference call.